Edition:
United States

Sino Biopharmaceutical Ltd (SBMFF.PK)

SBMFF.PK on OTC Markets Group

0.64USD
13 Sep 2016
Change (% chg)

-- (--)
Prev Close
$0.64
Open
--
Day's High
--
Day's Low
--
Volume
46
Avg. Vol
7,400
52-wk High
$1.01
52-wk Low
$0.61

Summary

Name Age Since Current Position

Y Y Tse

22 2015 Executive Chairman of the Board

Ping Tse

63 2016 Chief Executive Officer, Executive Director

Minggang Wang

58 2008 Vice Chairman of the Board and the General Manager of Qingdao Haier

Yong Zhu

2015 President of Jiangsu Qingjiang

Hsin Tse

45 Vice President, Executive Director

Mingqin Li

56 2015 Vice President, Executive Director

Sau Fung Leung

2008 Vice President, Company Secretary

Xiaoguang Shen

43 2008 General Manager - Investment Management Department, Assistant to Directors

Hsuan Tse

45 2008 General Manager - Information Management Department

Wei Nong Ye

52 Assistant President, Deputy General Manager - R&D Department

Chau Ling Yu

Assistant Vice President, Financial Controller, Qualified Accountant

Zhoushan Tian

51 2015 Executive Director

Shanchun Wang

47 2015 Executive Director

Hui Cheng

51 Deputy Financial Controller

Fai Chia

Assistant to the Chairman, Personnel Manager

Chun Ling Li

43 Vice President of CTT

Jinming Li

50 2005 Deputy General Manager of LYG Tianqing

Zhaocheng Tang

48 Vice President of CTT

Wun Tse

Assistant to the Chairman

Hong Wang

51 Deputy General Manager of LYG Tianqing

Junping Wang

2014 General Manager of Shanghai Tongyong

Kuanqi Wang

48 Deputy General Manager of NJCTT

Xiangjian Wang

44 Vice President of CTT

Wenyu Xia

46 2014 General Manager and Director of Jiangsu Fenghai

Jie Zhang

44 Vice President of CTT

Xiquan Zhang

45 Chief Engineer of CTT

Yangqing Zhang

46 Deputy General Manager of finance department of NJCTT

Zhenqian Zhang

45 Deputy General Manager and Engineer of NJCTT

Xinglong Zhuang

45 Assistant to the President and Secretary of the board of CTT

Dakui Li

71 2004 Independent Non-Executive Director

Hong Lu

47 2015 Independent Non-Executive Director

Zhengfei Lu

53 2005 Independent Non-Executive Director

Lu Fu Zhang

57 2015 Independent Non-Executive Director

Biographies

Name Description

Y Y Tse

Miss. Tse, Theresa Y Y is Executive Chairman of the Board of the Company. She holds a Bachelor Degree of Science in Economics from the Wharton School of University of Pennsylvania. Throughout her coursework, she focused on the study of Finance and Healthcare. Previously, she worked in the Investment, Finance and Business Development Departments of several companies. Save for the positions mentioned above, Miss Tse has not previously held and is not holding any position with the Company or any of its subsidiaries. She has not held any directorship in any other listed company in the last three years.s

Ping Tse

Mr. Tse Ping is Chief Executive Officer, Executive Director of the Company. He was an Executive Chairman of the Board of Sino Biopharmaceutical Ltd. He is the Founder of the Company. He is responsible for the overall operations of the Group. With more than 22 years of pharmaceutical related investment and management experience, he is currently a director of CT Tianqing, NJCTT, Jiangsu Fenghai, Jiangsu Qingjiang, Qingdao Haier, Qingdao Chia Tai Haier Medicines Co., Ltd., Qingdao Heng Seng Tang Pharmacy Co., Ltd., Beijing Tide and CT Green Continent. He is also a director of Shanghai Fortune World Development Co., Ltd., Tianjin Chiatai Feed Tech Co., Ltd., SYN Energy Technology Co., Ltd. and Chia Tai Oversea Chinese Realty Development Co., Ltd. He is also a non-executive director of Tianjin Binhai Teda Logistics (Group) Corporation Limited, the shares of which are listed on GEM Board of The Stock Exchange of Hong Kong Limited (the “Stock Exchange”). Mr. Tse was formerly the vice chairman of C.P. Lotus Corporation, the shares of which are listed on the main board of the Stock Exchange. Mr. Tse was also formerly the vice chairman of Shenzhen 999 Pharmaceutical Co., Ltd, and was involved in the management of Hainan Haiyao Co., Ltd. (formerly known as Hainan Pharmaceutical Industrial Joint-Stock Company Limited, which is now listed on the Shenzhen Stock Exchange in the PRC. Mr. Tse was also formerly the chairman of Chia Tai Qingchunbao Pharmaceutical Co., Ltd. (“CTQ”) which is now a subsidiary of Shanghai Industrial Investment (Holdings) Co., Ltd., the chairman of Xian CP and the executive chairman of TM International Bank Co., Ltd, based in Shanghai. Mr. Tse is still a director of CTQ, a committee member of the Association of Pharmaceutical Biotechnology of China and an honoral professor of Shenyang University of Pharmacy.

Minggang Wang

Mr. Wang Minggang is the Vice Chairman of the Board and the General Manager of Qingdao Haier of Sino Biopharmaceutical Ltd. He joined the Group in September, 2008. He is also a practicing doctor and a senior engineer. Mr. Wang has worked in some -scale domestic and foreign pharmaceutical companies and he has more than 25 years of experience in the pharmaceutical industry. He has been the marketing director of Xian CP, the sales general manager of Beijing Sihuan Pharmaceutical Factory, and the general manager of Qingdao Haier. Mr. Wang is also a member of Qingdao Pharmaceutical Association, a member of Qingdao Medical Association, and a member of the Tenth Qingdao Laoshan District’s Committee of the Chinese People’s Political Consultative Conference.

Yong Zhu

Mr. Zhu Yong is the President of Jiangsu Qingjiang of the company. He was the marketing director of Jiangsu Fenghai since 2005, was mainly responsible for the marketing and academic promotion of new products, setting up the branch name of Fenghai, making the successful sales policies for market leading and development, and hence “New Model of Sugar Infusion Solution” of Jiangsu Fenghai was well received by the pharmaceutical industry. In 2008, as the sales vice president, he initiated Jiangsu Fenghai’s characteristic mixed marketing model (i.e. the use of agency and pure sales, and the integration of the sales of new products and generic medicines) successfully. In 2011, he was the executive vice president of Jiangsu Fenghai and was responsible for R&D, marketing and human resources, formed the medical R&D centre in Nanjing and set up the training system for all staff. In October 2014, he was acted as executive vice president of Jiangsu Qingjiang and was responsible for R&D, human resources and office administration. In January 2015 onwards, he is the president of Jiangsu Qingjiang and is responsible for all matters of Jiangsu Qingjiang.

Hsin Tse

Mr. Tse Hsin is an Executive Director, Vice President of Sino Biopharmaceutical Ltd. He is mainly responsible for the acquisition and merger activities of the Group. He is also the Group’s spokesman. Mr. Tse graduated from the University of Hong Kong with a Bachelor’s Degree (Honors) in Industrial Engineering. He joined the Group in August, 1995 as an assistant to the President of the Company and served as the general manager of Xian CP. Mr. Tse is a council member of the first council and the executive council member of the second council of Chaozhou Natives Chamber of Commerce Beijing. He is also an executive member of the Right Protection Association for the Medical Treatment Equipment Enterprises of the Shaanxi Province, the vice chairman of the fourth council of the Foreign Invested Enterprises Association of the Shaanxi Province, the executive member of the third committee of the Shaanxi Cancer Fighting Association and the vice chairman of the World Chinese Medicine and Pharmaceutical Professional Joint Committee. He was also awarded the “Outstanding Management Award for Foreigninvested Enterprises of Shaanxi Province” and “Outstanding Entrepreneur who cares about his staff” by the Shaanxi Provincial Government. He was an executive director of Beijing Tide. He is currently a director of CT Tianqing. He is a first cousin of Mr. Tse Ping, the Founder, Chairman and Executive Director of the Company.

Mingqin Li

Ms. Li Mingqin is the Vice President, Executive Director of Sino Biopharmaceutical Ltd. She is the director of Beijing Tide and Chia Tai Shaoyang Orthopedic Hospital. She is principally responsible for the investment affairs of the Group. Ms. Li graduated from the Faculty of Medicine of the Beijing Chinese Medicine University with a Bachelor Degree in medicine. Prior to joining the Company, Ms. Li has worked in Sino-Japanese Friendly Hospital and Beijing Chinese Medicine University, engaged in the teaching of medicines, R&D of new medicines and medicines management. During the period from 1992 to 1995, Ms. Li has been engaged in Post-doctorate research in the Medicine School of University of Colorado, USA and the Medical College in the University of Massachusetts. Ms. Li joined the Group in March, 1997 and she has 32 years of experience in the pharmaceutical industry.

Sau Fung Leung

Ms. Leung Sau Fung (Fanny) is Vice President, Company Secretary of Sino Biopharmaceutical Ltd. She joined the Group in February, 1992. She is responsible for overseeing the corporate compliance of the Group’s listed and statutory issues. She obtained a Honours Diploma in Company Secretaryship and Administration. She is an associate member of both the Institute of Chartered Secretaries and Administrators and The Hong Kong Institute of Company Secretaries. Before joining the Group, Ms. Leung worked in the Company Secretarial Department of an international audit firm.

Xiaoguang Shen

Mr. Shen Xiaoguang is General Manager - Investment Management Department and an Assistant to Directors of Sino Biopharmaceutical Ltd. Mr. Shen participates in the business development and management of the Group, and is responsible for the market analysis of main products and R&D of new products. Mr. Shen graduated from the Heilongjiang College of Business with a Bachelor Degree in Science in pharmaceutical manufacturing, and has about 17 years experience in pharmaceutical sales and marketing and product R&D. Mr. Shen joined the Group in February, 2003.

Hsuan Tse

Mr. Tse Hsuan (Johnny) is the General Manager - Information Management Department of Sino Biopharmaceutical Ltd. He joined the Group in January, 2003. He is principally responsible for the development and maintenance of information system for the Company. Mr. Tse graduated from the University of Oregon with a B.S. Degree in computer science in the United States. He also graduated from ESMOD Paris (Ecole International de Mode Paris) with a diploma in fashion design and pattern drafting. Before joining the Company, Mr. Tse worked in Beijing Major Kind Co., Ltd. engaged in fashion design and computer system maintenance. His design of uniform for air attendants was adopted by Air China.

Wei Nong Ye

Dr. Ye Wei Nong, Ph.D., is Assistant President, Deputy General Manager - R&D Department, subsidiary of Sino Biopharmaceutical Ltd. He is responsible for the Group’s development on Biotechnology. He is currently a director of China Biotech & Drug Development Limited and Jiangsu Fenghai. In 1983, Dr. Ye graduated from Zhongshan (Dr. Sun Yat-Sen) University in biochemistry with a bachelor degree in science. In 1989, Dr. Ye obtained a doctoral degree (Ph.D.) in microbiology in Institute National des Sciences Appliquees (INSA) de Toulouse of France. He also obtained a certificate of study for Masters specialised in marketing and food technology in Ecole Superieure de Commerce (ESC) de Toulouse of France. Prior to joining the Group in July, 2002, Dr. Ye worked in Europe and Hong Kong for biotechnology and pharmaceutical companies. Dr. Ye was a member of The Advisory Committee on Applied Biology and Chemical Technology of The Hong Kong Polytechnic University from February 2006 to September 2014. He is also a member of the 8th Subcommittee of Industrial Biochemistry and Molecular Biology under The Chinese Society of Biochemistry and Molecular Biology (CSBMB).

Chau Ling Yu

Ms. Yu Chau Ling, CPA, FCCA, is the Assistant Vice President, Financial Controller, Qualified Accountant of Sino Biopharmaceutical Ltd. She is qualified accountant of the Company. She graduated from the University of Hong Kong with a Bachelor Degree in Social Sciences and obtained the MBA degree from The Open University of Hong Kong in 2005. She is the fellow member and an associate member of the Association of Chartered Certified Accountants and the Hong Kong Society of Accountants respectively. Ms. Yu joined the Company in February, 2003 and has working experience in the international audit firm and listed companies.

Zhoushan Tian

Mr. Tian Zhoushan is the Executive Director of the Company. He joined the Group in April, 1997 and is responsible for the business of Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. (“NJCTT”). Mr. Tian is a vice president of CT Tianqing and the general manager of NJCTT. Mr. Tian completed MBA coursework in Nanjing University. He was the production manager and assistant to the president of CT Tianqing. Mr. Tian has 26 years of experience in the pharmaceutical industry.

Shanchun Wang

Mr. Wang Shanchun is the Executive Director of Sino Biopharmaceutical Ltd. He is currently the president of Chia Tai-Tianqing Pharmaceutical Holdings Co., Ltd. (“CT Tianqing”). He graduated from Nanjing University of Chemistry in July, 1990 and joined CT Tianqing in the same year. Mr. Wang studied a Master Degree in pharmaceutical engineering with Tianjin University from 1999 to 2002. He was a vice officer and an officer of the production plant, the deputy manager and the manager of engineering department, chief of GMP office, the vice general engineer, the general engineer and executive vice president. Mr. Wang has rich management experiences in the pharmaceutical field in the People’s Republic of China (“PRC”), his design of new preparation plant in CT Tianqing Haizhou was obtained the first GMP certificate of new edition GMP. He was awarded as Lianyungang City Technology Advancement Worker, Jiangsu Province Technology Advancement Worker, Jiangsu Province Labour Model and Jiangsu Province Science Technology Second Honour Award.

Hui Cheng

Ms. Cheng Hui is the Deputy Financial Controller of Sino Biopharmaceutical Ltd. Ms. Cheng joined the Group in May, 1993 and is responsible for the Group’s PRC financial and personnel issues. She has been the head of the finance department in China Construction Bank (Zaozhuang City Branch). Ms. Cheng has 24 years of working experience in finance and accounting. She was awarded the accountancy qualification certificate issued by Ministry of Finance and Ministry of State Personnel in 1992, and ACCA Chinese finance and accounting qualification certificate issued by Chartered Association of Certified Accountants. Ms. Cheng received international advanced human resources management professional training held by the International Public Management Association for Human Resources (IPMA-HR).

Fai Chia

Ms. Chia Fai is Assistant to the Chairman, Personnel Manager of Sino Biopharmaceutical Ltd. Ms. Chia joined the Group in November, 1991 and has more than 25 years of experience in financial area. Ms. Chia is a director of various companies including Chia Tai Pharmaceutical (Lianyungang) Company Limited, Chia Tai Refined Chemical Industry Limited, Evon Industries Limited, Talent Forward Limited, Sino Biopharmaceutical (Beijing) Limited and Magnificent Technology Limited.

Chun Ling Li

Ms. Li Chun Ling is Vice President of CTT, subsidiary of Sino Biopharmaceutical Ltd. She is responsible for the financial and accounting affairs of CTT. Ms. Li joined the Group in February, 1996 and was a manager in the audit department and finance and accounting department of the Group. Ms. Li graduated from Guizhou College of Finance and Accounting. Before joining the Group, Ms. Li had worked in audit firms and as a team in-charge for social auditing of projects. Ms. Li has over 16 years experience in finance and accounting, and is a Certified Accountant in the PRC.

Jinming Li

Mr. Li Jinming is the Deputy General Manager of LYG Tianqing of Sino Biopharmaceutical Ltd. Mr. Li studied in the pharmaceutical major of Chinese Pharmaceutical University. Mr. Li holds the MBA Degree awarded jointly by Huadong University of Science and Technology and America University of Management and Technology. Mr. Li has over 15 years experience as district manager in pharmaceutical sales in two well-known pharmaceutical enterprises in the PRC. He was the district manager of JCTT for five years. Mr. Li has sales and management experience.

Zhaocheng Tang

Mr. Tang Zhaocheng is Vice President of CTT of Sino Biopharmaceutical Ltd. He is responsible for the production management of JCTT. Mr. Tang joined JCTT in April, 1997. He has a professional qualification in chemical engineering. Mr. Tang has been a vice officer in technological production, and a manager in quality control as well as a chief officer in GMP and assistant to president of JCTT. He has been a team leader in the production of Ganlixin and Zegui Longshuang in JCTT. Mr. Tang has over 21 years of experience in the pharmaceutical industry.

Wun Tse

Ms. Tse Wun is an Assistant to the Chairman of Sino Biopharmaceutical Ltd. She joined the Group in November, 1991. She is principally responsible for the Group’s administration and financial matters in Hong Kong. Ms. Tse graduated from the University of Oregon with a B.S. degree. She was formerly a director of Shenzhen 999 Pharmaceutical Co., Ltd. and has 16 years of experience in finance and investment.

Hong Wang

Mr. Wang Hong is a Deputy General Manager of LYG Tianqing, subsidiary of Sino Biopharmaceutical Ltd. He is responsible for the sales management. Mr. Wang graduated from Shanghai Medical University in 1991 with a Master degree in medical science. He also holds an MBA Degree from the Business School of the National University of Singapore. He was the Derm Franchise Sales Manager of Xian-Janssen Pharmaceutical Ltd. where he had worked for 8 years. Mr. Wang has more than 15 years of experience in sales and he joined the Group in December, 2002, he was a vice president of JCTT and was responsible for sales management.

Junping Wang

Mr. Wang Junping is the General Manager of Shanghai Tongyong of the company. He joined the Group in July 2014. He obtained the Bachelor Degree in Material Science and Chemical Application faculty from the National University of Defense Technology in 1989 and obtained the MBA from Tinajin University Management College in 2000. He studied the industrial property rights management from The Association for Overseas Technical Scholarship in Japan. He has 25 years of experience in the pharmaceutical industry. He was the senior management of North China Pharmaceutical Group Corporation, Shanghai Fosun Pharmaceutical Industry Development Co., Ltd. and Fu Jen Pharmaceutical Group and was responsible for R&D, quality control, policy making and sales management.

Kuanqi Wang

Mr. Wang Kuanqi is Deputy General Manager of NJCTT of Sino Biopharmaceutical Ltd. He is responsible for production. Mr. Wang graduated from Changzhou Chemical Institute with the profession qualification in organic synthesis. He joined JCTT in 1988. He studied pharmacy with China Pharmaceutical University from 1999 to 2002. He was a team leader and an officer of the production plant, the production manager and an assistant to general manager.

Xiangjian Wang

Mr. Wang Xiangjian is a Vice President of CTT of the company. He graduated from Nankai University and holds a Bachelor Degree in Molecular Biology. Mr. Wang joined the Group in June, 1994 and is responsible for CTT’s R&D Institute.

Wenyu Xia

Mr. Xia Wenyu is the General Manager and Director of Jiangsu Fenghai of the company. He has a professional qualification in finance and accounting discipline with tertiary education level and is an accountant. He was graduated from the Renmin University of China with the MBA Degree. He is a general manager and director of Jiangsu Fenghai since September 2014 and was the financial officer, a deputy head of Corporate Restructuring Committee, a manager of Planning and Finance Unit, board secretary, an assistant to general manager and a manager of logistic department, the sales director and the deputy general manager. He has ample experience of managing the corporate, sales, human resources and financial issues and has 28 years of experience in the pharmaceutical industry. He is an executive director of China Price Association and Jiangsu Province Medical Insurance Committee.

Jie Zhang

Mr. Zhang Jie is a Vice President of CTT. He graduated from Henan University and holds the MBA Degree. Mr. Zhang joined the Group in July, 1993 and is responsible for the office affairs of CTT.

Xiquan Zhang

Mr. Zhang Xiquan is the Chief Engineer of CTT of Sino Biopharmaceutical Ltd. Mr. Zhang graduated from Nankai University in 1994 with a M.S. Degree. He has carried out studies of a number of new drugs with experience in drug candidate selection and drug development with partners. Mr. Zhang joined CTT in April, 1997.

Yangqing Zhang

Mr. Zhang Yangqing is the Deputy General Manager of finance department of NJCTT of the company. He was graduated from Central South University with a Bachelor Degree of Industrial Management Engineering. He is a registered accountant and registered Real Estate appraiser with practicing qualification. He was a member of National Development and Reform Commission of Ziyang District of Yiyang City in Hunan Province, civil servant of Housing Administrative Bureau of Yiyang City, an audit manager of Hunan Kaiyuan CPA, a financial controller of Chengdu Jiuzhitang Jinding Pharmaceutical Ltd., a vice minister of finance department and sales officer of Jiuzhitang Co., Ltd., audit head of CT Tiangqing, a finance manager of Chia Tai Pharmaceutical Group and a deputy general manager of finance department of Jiangsu Fenghai.

Zhenqian Zhang

Mr. Zhang Zhenqian is Deputy General Manager and Engineer of NJCTT of Sino Biopharmaceutical Ltd. Mr. Zhang joined the Group in April, 1997 and is responsible for the sales and operation of NJCTT. Graduated from Xuzhou College of Engineering, Mr. Zhang has completed the studies in EMBA program in Guanghua Management School in Beijing University. Mr. Zhang has over 16 years experience in pharmaceutical industry and was a branch manager, major district manager of JCTT.

Xinglong Zhuang

Mr. Zhuang Xinglong is the Assistant to the President and Secretary of the board of CTT of the company. He graduated from Heilongjiang University of Chinese Medicine and holds a Bachelor Degree in Chinese Medicine. Mr. Zhuang joined the Group in January, 2008 and is currently the secretary of the board of CTT.

Dakui Li

Mr. Li Dakui is an Independent Non-Executive Director of Sino Biopharmaceutical Ltd. He is a member of the AC since September, 2004. He graduated from the Faculty of Pharmacy of Beijing Medical University (now named Faculty of Medicine and Pharmacy of Beijing University) in 1965. In 1982, he obtained a Master Degree in Pharmaceutics from Peking Union Medical College (“PUMC”) and is the chief pharmacist of PUMC Hospital and used to be a director of Pharmacy Department of PUMC Hospital for years. Mr. Li is also a vice president of the Chinese Pharmaceutical Association, the Chairman of the Committee of Hospital Pharmacy Branch of Chinese Pharmaceutical Association, the vice chairman of the Chinese Practicing Pharmacist Association, a vice editor of Chinese Pharmaceutical Magazine and Chinese Hospital Pharmaceutical Journal and Chinese Journal of Hospital Pharmacy, a member of the Chinese Pharmaceutical Committee and vice team leader of its medicine professional team, a member of the Drug Evaluation Committee of State Food and Drug Administration of China. Mr. Li is a member of advisory committee on safety of medicinal products meeting organized by World Health Organization. Mr. Li is an independent director of Changzhou Qianhong Bio-pharma Co., Ltd., its shares are listed on the Shenzhen Stock Exchange.

Hong Lu

Ms. Lu Hong is an Independent Non-Executive Director of the Company. Ms. Lu has over 20 years of experience in accounting, financial management, company secretarial and domestic and overseas capital operations field. She is a member of the Chinese Institute of Certified Public Accountants (“CICPA”), Hong Kong Institute of Certified Public Accountants (“HKCPA”) and a fellow member of the Association of Chartered Certified Accountants (“FCCA”). Ms. Lu has extensive knowledge in accounting and the listing rules and regulations both in Hong Kong and PRC. She has rich experience in the listing of corporations in the PRC, Hong Kong, Singapore and the United States of America and foreign and domestic investment and financing operations as well as mergers and acquisitions. Ms. Lu is familiar with financial analysis, budgeting, financial management and tax planning. She is also expertise in dealing with complex financing and taxation matters.

Zhengfei Lu

Mr. Lu Zhengfei is Independent Non-Executive Director of Sino Biopharmaceutical Ltd. He is the chairman of the AC and a member of the RC. He received P.h.D. Degree in Economics with concentration in financial management. Mr. Lu is currently the Vice Chairman, Professor and supervisor of doctoral students, Guanghua School of Management of Peking University. He has previously held various senior positions in the Department of Accounting of both Peking University and Nanjing University. He is the consulting of the China Financial Accounting Standards Board, Ministry of Finance. He is also a director of the China Accounting Association and an executive director of the China Auditing Association. Mr. Lu is the editor of several accounting and finance journals and he has issued various publications. He is an independent non-executive director of China National Materials Co. Ltd. and Sinotrans Limited and an independent supervisor of PICC Property and Casualty Company Limited, whose shares are listed on the Stock Exchange.

Lu Fu Zhang

Mr. Zhang Lu Fu is an Independent Non-Executive Director of the Company. Mr. Zhang holds a Master’s degree in Philosophy from the Beijing Normal University, is a research associate and a part-time professor. Mr. Zhang has been working for the Chinese government since 1987 including the Xin Hua News Agency branch in Hong Kong (Liaison Office of the Central People’s Government in Hong Kong). Since 2000, Mr. Zhang has worked for a number of Hong Kong listed companies and charitable organisations on a full-time and part-time basis in the capacity such as chief representative of Chinese affairs, Chinese affairs consultant, chief secretary for Chinese affairs and chief executive. In 2006, Mr. Zhang was appointed as the council member of the Shenzhen Overseas Friendship Association. In 2008, Mr. Zhang was appointed as a member of the Shenzhen Committee of the 4th Chinese People’s Political Consultative Conference and in 2013 he was appointed as the council member of the China Overseas Friendship Association. In 2009 and 2011, Mr. Zhang was employed by the Hong Kong Academy of Management and the Hong Kong Financial Services Institute respectively as a professor on a part-time basis. Save for the position mentioned above, Mr. Zhang has not previously held and is not holding any position with the Company or any of its subsidiaries. Mr. Zhang is an independent non-executive director of Kingboard Laminates Holdings Limited, the shares of which are listed on the Main Board of the Stock Exchange. Save as disclosed, Mr. Zhang has not held any directorship in any other listed company in the last three years.